Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Long-Term Debt Repayments (2022 - 2025)

Historic Long-Term Debt Repayments for Cytek Biosciences (CTKB) over the last 4 years, with Q3 2025 value amounting to $145000.0.

  • Cytek Biosciences' Long-Term Debt Repayments rose 357.14% to $145000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 24838.71%. This contributed to the annual value of $557000.0 for FY2024, which is 141.59% down from last year.
  • As of Q3 2025, Cytek Biosciences' Long-Term Debt Repayments stood at $145000.0, which was up 357.14% from $142000.0 recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Long-Term Debt Repayments registered a high of $1.5 million during Q1 2025, and its lowest value of $50000.0 during Q4 2022.
  • Moreover, its 4-year median value for Long-Term Debt Repayments was $140000.0 (2023), whereas its average is $248083.3.
  • In the last 5 years, Cytek Biosciences' Long-Term Debt Repayments tumbled by 479.45% in 2024 and then surged by 99208.63% in 2025.
  • Over the past 4 years, Cytek Biosciences' Long-Term Debt Repayments (Quarter) stood at $50000.0 in 2022, then soared by 180.0% to $140000.0 in 2023, then decreased by 0.71% to $139000.0 in 2024, then grew by 4.32% to $145000.0 in 2025.
  • Its Long-Term Debt Repayments was $145000.0 in Q3 2025, compared to $142000.0 in Q2 2025 and $1.5 million in Q1 2025.